Search results
Livelsberger Financial Advisory Invests $26,000 in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 3 days agoLivelsberger Financial Advisory purchased a new position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) during the fourth quarter, according to the company in its most recent disclosure ...
Biogen Inc. (NASDAQ:BIIB) Receives $286.50 Consensus Target Price from Analysts
ETF DAILY NEWS· 7 days agoShares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-six brokerages that are covering the firm, MarketBeat Ratings ...
AbbVie (NYSE:ABBV) Shares Up 0%
ETF DAILY NEWS· 6 days agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 0% during mid-day trading on Thursday . The company traded as high as $166.45 and last traded at $166.15. ABBV has been the topic ...
Drug names: How companies and regulators come up with hundreds of new names every year
Quartz· 2 days agoEverything you need to know about the art and science of drug naming in five minutes or less,...
Amgen Inc. (NASDAQ:AMGN) Sees Significant Drop in Short Interest
ETF DAILY NEWS· 4 days agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) was the recipient of a large decrease in short interest in May. As of May 31st, there was short interest totalling 9,050,000 shares, a decrease of ...
Gerber LLC Makes New $342,000 Investment in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 4 days agoGerber LLC bought a new stake in Amgen Inc. (NASDAQ:AMGN – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission ...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Morningstar· 3 days agoApproval supported by two Phase 3 clinical trials that evaluated SKYRIZI® for the treatment of moderate to severe ulcerative colitis: a 12-week induction study, INSPIRE,1 and a 52-week maintenance study, COMMAND2Data showed that clinical remission,
AbbVie Inc. (NYSE:ABBV) Shares Sold by Garde Capital Inc.
ETF DAILY NEWS· 6 days agoGarde Capital Inc. lowered its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 60.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Capital Market Strategies LLC
ETF DAILY NEWS· 1 day agoCapital Market Strategies LLC cut its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 4.8% during the 1st quarter, HoldingsChannel reports. The fund owned 10,376 shares of the company’s stock ...
175 Shares in Amgen Inc. (NASDAQ:AMGN) Acquired by Livelsberger Financial Advisory
ETF DAILY NEWS· 3 days agoLivelsberger Financial Advisory purchased a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The ...